New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: synthesis, characterization, computational studies and investigation of their interactions with the Human Serum Albumin-Reference-Cited by-同舟云学术

New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: synthesis, characterization, computational studies and investigation of their interactions with the Human Serum Albumin

Published:2024-07 Issue: Volume:567 Page:122060
ISSN:0020-1693
Container-title:Inorganica Chimica Acta
language:en
Short-container-title:Inorganica Chimica Acta

Author:

Gaitan Tabares Julie Pauline,Silva Ribeiro Santos Rodrigo Luis,Luiz Cassiano Jefferson,Reis Nascimento Ruan,Honorato João,Quispe Martínez Sandra,Bezerra Viana Rommel,Leal Savedra Ranylson Marcello,Batista Alzir Azevedo,de Oliveira Silva Denise

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Universidade Estadual de Santa Cruz

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

FAPESP

Publisher

Elsevier BV

Reference143 articles.

1. Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective

2. NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry

3. Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy

4. Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy

5. Metal-based antitumour drugs in the post-genomic era: what comes next?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the interaction mechanism between orphan drug Nitisinone and bovine serum albumin through spectroscopic and in silico approaches;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-12